Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DEPDC1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TUBA1C - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
UBE2L3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MVD - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RTN4R - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ZC3H18 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DUSP5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TUBA1B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LRRC1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RPN2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
UBL5 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MKI67 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
KRT18 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PGK1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NAP1L4 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TIA1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SREBF2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SMCHD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MAPK1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on